Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly/Isis Affinitak Pivotal Trial Fails: Future Rests On Second Phase III Study

Mar 24 2003

• By The Pink Sheet

Related Content

Aventis/Genta Genasense Lead Indication To Be Decided This Summer

May 06 2002

Lilly/Isis Lung Cancer NDA Possible In 2003; Lymphoma Indication In Phase II

Aug 27 2001

ClinicalTrials.Gov Lists 22 Lilly Studies; Response To FDA Deadline Is Mixed

Jun 03 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window